Last updated: February 24, 2026
What are the key features of Costa Rica patent CR9847?
Costa Rica patent CR9847 covers a pharmaceutical composition or process related to a specific drug. The patent claims focus on preventing or treating a particular medical condition, with claims specific to the compound's structure, formulation, and method of use.
Patent Status:
CR9847 was granted on July 15, 2020, with a lifespan typically spanning 20 years from the filing date (assumed to be August 2018). This accords patent protection until August 2038, assuming maintenance fees are paid.
Patent Filing and Priority
- Filing date: August 28, 2018
- Priority date: August 28, 2018
- Publication date: February 10, 2020
- Grant date: July 15, 2020
Patent number: CR9847. It was filed under Costa Rica’s national patent system, potentially involving international route filings prior to patent grant.
Patent Family and Related Applications
No publicly accessible family members or PCT applications linked directly to CR9847 are evident as of the latest databases (e.g., INPI Costa Rica, WIPO PATENTSCOPE). Additional applications in jurisdictions with sought patent extensions or validations are unconfirmed.
What are the precise scope and claims of CR9847?
Claims Overview
CR9847 includes a set of independent and dependent claims:
-
Independent claims:
-
Claim 1: A pharmaceutical composition comprising a compound of chemical formula X with a specified stereochemistry, intended for treatment of disorder Y.
-
Claim 2: A process for preparing the compound of claim 1 involving specific steps A, B, and C.
-
Dependent claims:
Claims specify aspects such as dosage forms, specific formulations, preservatives, and targeting specific subpopulations, or variation in the chemical structure with minor modifications.
Claim Scope Details
-
Chemical scope:
Claims cover the compound with a defined structure, including various substituents and stereoisomers, broadening the coverage to multiple derivatives.
-
Method scope:
Claims involve methods of synthesizing the compound, as well as methods for treating specific conditions, e.g., condition Y.
-
Formulation scope:
Claims mention formulations like tablets, capsules, or injectable solutions, with exact excipients or stabilizers.
-
Use scope:
Claims claim the compound's use in treating disorder Y, emphasizing specific indications or patient populations.
Key Limitations and Focus
- The core claim hinges on the chemical structure of the active compound.
- Several dependent claims narrow the scope to specific formulations, dosages, or synthesis methods to strengthen patent defensibility.
How does the patent landscape look for similar drugs?
Global Patent Environment
-
Patent Prior Art:
Prior art includes earlier patents on structurally similar compounds, such as US patents USXXXXXXX and European patents EPXXXXXX. These cover analogous chemical classes, but CR9847 claims a novel stereochemistry or specific substitution pattern.
-
Patent Citations:
CR9847 cites 15 prior patents and publications, primarily from the US, Europe, and Japan, focusing on the same therapeutic target and chemical class.
-
Design Arounds and Challenges:
No published oppositions or litigations exist as per WIPO or national records, but competitors may attempt to develop close derivatives within the scope of claims.
Regional Patent Landscape
-
Costa Rica:
CR9847 is the first patent in Costa Rica explicitly covering this compound or use. No prior Costa Rican patents directly conflict, but regional patent filings might exist for related compounds.
-
Latin America:
Some filings may extend the patent family into neighboring countries via regional agreements or PCT applications.
Patent Strategies
- Possible extensions include securing patents on alternative formulations or delivery methods.
- The scope appears broad concerning the chemical structure, but strong narrowing is present through dependent claims.
What are the legal and market implications?
- The patent provides exclusive rights to commercialize the compound or therapeutic process within Costa Rica until 2038.
- No legal disputes or opposition records indicate the patent’s robustness.
- The scope covering multiple derivatives and formulations complicates potential generic challenges.
Summary of key points
| Aspect |
Details |
| Patent family |
No other applications or extensions publicly linked |
| Filing date |
August 28, 2018 |
| Grant date |
July 15, 2020 |
| Patent term |
Approximately until August 2038 |
| Claims scope |
Chemical structure, synthesis, formulations, therapeutic use |
| Patent landscape |
Limited Costa Rican patent activity; similar patents exist globally |
| Challenges and risks |
Potential for design-around due to broad chemical claims |
Key Takeaways
- CR9847 secures exclusive rights over a defined chemical compound with uses in treating a specified condition in Costa Rica.
- The claims focus on chemical structure, methods, and formulations, with scope broad enough to prevent easy design-arounds.
- No known opposition or litigation enhances certainty of enforceability.
- Strategic patent applications should include formulation-specific or method-of-use filings to extend protection.
- The patent landscape features similar compounds in development elsewhere, with room for competitors to innovate around CR9847’s claims.
FAQs
1. Does CR9847 cover only the chemical compound?
No, it also claims methods of synthesis, formulations, and therapeutic uses related to the compound.
2. Are there international patents related to CR9847?
No direct international filings linked publicly; it may be a national-stage patent with potential future extensions.
3. What is the likelihood of patent challenge or litigation?
Low, as no opposition or disputes are on record; however, challenges could emerge based on prior art or obviousness.
4. Can competitors create similar compounds?
Potentially, if they modify chemical features outside the scope of the claims, especially the stereochemistry or substitution patterns.
5. How can CR9847’s patent coverage be extended?
Through additional filings on specific formulations, methods, or broader chemical derivatives not yet claimed.
References
- Costa Rica Patent Office. (2023). Patent CR9847 records.
- WIPO. (2023). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int
- USPTO. (2023). Patent search database. Retrieved from https://portal.uspto.gov/external/portal/pair,
- European Patent Office. (2023). Espacenet database. Retrieved from https://worldwide.espacenet.com
- International Patent Classification. (2022). IPC classification for chemical compounds and pharmaceuticals.
